Description
The active ingredient anastrozole belongs to the aromatase inhibitor group and is used to treat postmenopausal women with breast cancer. The effect is based on the inhibition of the enzyme aromatase, which plays an essential role in the formation of estrogens. Inhibition of aromatase inhibits the conversion of androgens into estrogens, thus preventing the growth of hormone-dependent tumor cells.
This medicine contains substances that may be classified as doping substances.
Reviews
There are no reviews yet.